Touchlight Genetics
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Morelands & Riverdale Buildings Lower Su...Phone Number
+44 2084819200Website
www.touchlight.comRevenue
$21.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Touchlight Genetics
Touchlight is a privately-owned biotechnology company based in London, U.K., focussed on the discovery and development of DNA-based genetic medicines, including DNA vaccines and gene therapies. Touchlight has developed a novel, synthetic DNA vector known as "doggybone" or dbDNA. Established in 2007, Touchlight Genetics has a head office in Hampton, London, United Kingdom.Explore more
Touchlight Genetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Touchlight Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Touchlight Genetics launches new products
Check out if Touchlight Genetics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Touchlight Genetics
Click to see if Touchlight Genetics had a recent Job posting/layoffs
Earning: See what the market has to say on Touchlight Genetics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Touchlight Genetics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Touchlight Genetics has new funding data
Touchlight Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Touchlight Genetics
Find more new buyers
Compare Similar Companies to Touchlight Genetics
Compare insights from companies similar to Touchlight Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Touchlight Genetics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Touchlight Genetics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Touchlight Genetics.
Touchlight Genetics financials insights
Gather financial insights about Touchlight Genetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$58M
Touchlight Genetics Tech Stack
A closer look at the technologies used by Touchlight Genetics
Most Recent Scoops
Hiring Plans
Touchlight Genetics has more open roles in Marketing than it has had at any time in the past 12 months. Areas of expertise include: Go-to-Market Strategy, Campaign Management, Social Media, Content Marketing, Lead Nurturing, Campaign Performance Analysis, and Demand Generation.
Hiring Plans
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Event
will be attending the Advanced Therapies Week conference as an exhibitor. The event will occur from January 17 to January 20, 2023.
Funding
Touchlight Genetics News & Media
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study
HAMPTON, England--(BUSINESS WIRE)--Touchlight's enzymatic dbDNA used as a critical starting material for Versameb's VMB-100, for first-in-human clinical study to treat chronic SUI.Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London, UK
HAMPTON, England--(BUSINESS WIRE)--Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine treatments, has completed the redevelopment and expansion of its UK manufacturing facility, housed in a repurposed Victorian waterworks on the banks of the River Thames. The expanded state-of-the-art facility’s manufacturing capacity has tripled and is now capable of producing more than 8kg a year. This exceeds the current, but growing, global supply ofTouchlight Announces First FDA Clearance of an IND Utilising Doggybone DNA
HAMPTON, England--(BUSINESS WIRE)--Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) application in the US utilising doggybone DNA (dbDNA™). Within the trial now planned by one of Touchlight’s clients, dbDNA will be used as an in vitro transcription template for mRNA production in the manufacturing of a cell therapy product. The trial sponsor has operational facilities across the US. TFDA Accepts Drug Master File, Signifying a New Milestone for Touchlight’s Enzymatic doggybone DNA Technology
HAMPTON, England--(BUSINESS WIRE)--Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a ground-breaking new milestone for its enzymatic doggybone DNA (dbDNA™), following the FDA acceptance of the Drug Master File (DMF) for GMP grade dbDNA. This achievement marks the first time a DMF has been accepted for an enzymatically produced DNA platform, representing a sign of the growing interest and adoption of enzymatic DNA across the ge
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Touchlight Genetics
Sign Up For FreeTo access detailed company insights
Touchlight is a privately-owned biotechnology company based in London, U.K., focussed on the discovery and development of DNA-based genetic medicines, including DNA vaccines and gene therapies. Touchlight has developed a novel, synthetic DNA vector known as "doggybone" or dbDNA. Established in 2007, Touchlight Genetics has a head office in Hampton,... Read More
